SGM-101 in Locally Advanced and Recurrent Rectal Cancer

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

203

Participants

Timeline

Start Date

October 22, 2019

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2023

Conditions
Rectal CancerRecurrent Rectal Cancer
Interventions
DRUG

SGM-101

Fluorescence-guided surgery

Trial Locations (4)

Unknown

RECRUITING

Amsterdam University Medical Center, Amsterdam

RECRUITING

Catharina Hospital Eindhoven, Eindhoven

RECRUITING

Erasmus Medical Center, Rotterdam

NOT_YET_RECRUITING

Haaglanden Medisch Centrum, The Hague

Sponsors
All Listed Sponsors
collaborator

Erasmus Medical Center

OTHER

collaborator

Amsterdam UMC, location VUmc

OTHER

collaborator

Catharina Ziekenhuis Eindhoven

OTHER

collaborator

Medical Center Haaglanden

OTHER

collaborator

Surgimab

INDUSTRY

collaborator

Quest Medical Imaging

INDUSTRY

collaborator

Centre for Human Drug Research, Netherlands

OTHER

lead

Leiden University Medical Center

OTHER